Search

9 May 2024 - This document provides a list of biosimilar medicines that have been approved by the Therapeutic Goods Administration for supply in Australia.

3 June 2025 - This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. It explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

11 June 2025 - These guidelines contain the general, initial and ongoing eligibility requirements to access treatment for late-infantile onset Batten disease under the Life Saving Drugs Program.

12 February 2026 - MBS Eating Disorders Treatment and Management Plan (EDTMP) provides affordable evidence-based care for people with eating disorders. People who are eligible for an EDTMP can access Medicare benefits for up to 40 psychological and 20 dietetic services over a 12-month period.

17 January 2024 - The Targeted Translation Research Accelerator Plan Expert Advisory Panel (EAP) advised on investments under the Medical Research Future Fund (MRFF) for research into diabetes and cardiovascular disease.

16 June 2025 - This public summary document outlines Stoma Product Assessment Panel recommendations, after assessing products for the Stoma Appliance Scheme Schedule in October 2023.

27 November 2025 - Read progress on recommendation 11.17 of the Disability Royal Commission.

18 December 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 15 December 2021.

7 September 2023 - The Stem Cell Therapies Mission Expert Advisory Panel (EAP) advised the government on the research priorities for this mission, which is funded by the Medical Research Future Fund (MRFF).

8 June 2022 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a first booster dose in adolescents aged 12-15 years.